Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
memo - Magazine of European Medical Oncology
Published in: memo - Magazine of European Medical Oncology 3/2021

01-09-2021 | Multiple Myeloma | editorial

Interesting news from the annual meeting of the American Society of Hematology 2020

Author: Univ.-Doz. Dr. Eberhard Gunsilius

Published in: memo - Magazine of European Medical Oncology | Issue 3/2021

Login to get access

Excerpt

The 62nd annual meeting of the American Society of Hematology, the most influential meeting in hematology, was held (formally in San Diego, CA, USA) as an all-virtual meeting from December 5–8, 2020. Apart from outstanding contributions “from the bench” with the potential to find a way into diagnosis and treatment, a plethora of clinical trials, many in early clinical phase investigating novel compounds, were presented. In this issue of MEMO, selected presentations that are relevant for our daily practice or are likely to become relevant in the near future are highlighted by esteemed colleagues, to whom I express my thanks for the preparation of their manuscripts. …
Literature
1.
2.
3.
Metadata
Title
Interesting news from the annual meeting of the American Society of Hematology 2020
Author
Univ.-Doz. Dr. Eberhard Gunsilius
Publication date
01-09-2021
Publisher
Springer Vienna
Published in
memo - Magazine of European Medical Oncology / Issue 3/2021
Print ISSN: 1865-5041
Electronic ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-021-00733-1

Other articles of this Issue 3/2021

memo - Magazine of European Medical Oncology 3/2021 Go to the issue

case report

A patient with liver cirrhosis and hepatic lesions

editorial

Pediatric oncology 2.0—shaping the future with precision

case report

Sphenoidal mucormycosis associated with large B-cell lymphoma: case report and literature review

case report

Death of unknown cause? Post-mortem diagnosis of fulminant course of an EBV-associated secondary hemophagocytic lymphohistiocytosis

case report

Lethal human metavirus pneumonia in a patient with chronic lymphocytic leukemia

short review

SABCS 2020: update on triple-negative and metastatic HER2-positive breast cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits